nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—Chills—Leflunomide—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Mometasone—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Mometasone—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Carboprost Tromethamine—Respiratory failure—Methotrexate—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Captopril—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Carboprost Tromethamine—Chills—Mycophenolic acid—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Carboprost Tromethamine—Shock—Captopril—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Carboprost Tromethamine—Back pain—Leflunomide—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Captopril—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Carboprost Tromethamine—Pain—Mometasone—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Leflunomide—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Leflunomide—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Carboprost Tromethamine—Asthenia—Pentoxifylline—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Carboprost Tromethamine—Tension—Mycophenolic acid—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Carboprost Tromethamine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Carboprost Tromethamine—Back pain—Mycophenolic acid—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Lisinopril—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Carboprost Tromethamine—Flushing—Lisinopril—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Carboprost Tromethamine—Angioedema—Leflunomide—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Carboprost Tromethamine—Myalgia—Azathioprine—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Carboprost Tromethamine—Vertigo—Leflunomide—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Mometasone—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Captopril—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Carboprost Tromethamine—Chills—Lisinopril—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Carboprost Tromethamine—Palpitations—Leflunomide—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Captopril—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Carboprost Tromethamine—Somnolence—Captopril—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Carboprost Tromethamine—Cough—Leflunomide—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Methotrexate—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Carboprost Tromethamine—Lethargy—Prednisone—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Carboprost Tromethamine—Dizziness—Pentoxifylline—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Carboprost Tromethamine—Hypertension—Leflunomide—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Carboprost Tromethamine—Infection—Azathioprine—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Carboprost Tromethamine—Vertigo—Mycophenolic acid—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Carboprost Tromethamine—Syncope—Mycophenolic acid—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Carboprost Tromethamine—Chest pain—Leflunomide—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Carboprost Tromethamine—Myalgia—Leflunomide—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Carboprost Tromethamine—Anxiety—Leflunomide—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Carboprost Tromethamine—Tension—Lisinopril—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Carboprost Tromethamine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Carboprost Tromethamine—Nervousness—Lisinopril—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Carboprost Tromethamine—Cough—Mycophenolic acid—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Carboprost Tromethamine—Back pain—Lisinopril—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Carboprost Tromethamine—Vomiting—Pentoxifylline—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Lisinopril—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Carboprost Tromethamine—Rash—Pentoxifylline—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Carboprost Tromethamine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Carboprost Tromethamine—Headache—Pentoxifylline—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Carboprost Tromethamine—Chest pain—Mycophenolic acid—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Carboprost Tromethamine—Myalgia—Mycophenolic acid—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Carboprost Tromethamine—Infection—Leflunomide—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Lisinopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Carboprost Tromethamine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Carboprost Tromethamine—Asthenia—Mometasone—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Leflunomide—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Carboprost Tromethamine—Angioedema—Lisinopril—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Captopril—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Carboprost Tromethamine—Nausea—Pentoxifylline—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Carboprost Tromethamine—Chills—Mycophenolate mofetil—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Carboprost Tromethamine—Infection—Mycophenolic acid—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Carboprost Tromethamine—Vertigo—Lisinopril—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Mometasone—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Carboprost Tromethamine—Syncope—Lisinopril—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Carboprost Tromethamine—Shock—Mycophenolic acid—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Carboprost Tromethamine—Palpitations—Lisinopril—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Carboprost Tromethamine—Cough—Lisinopril—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Carboprost Tromethamine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Leflunomide—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Carboprost Tromethamine—Myalgia—Lisinopril—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Carboprost Tromethamine—Chest pain—Lisinopril—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Carboprost Tromethamine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Carboprost Tromethamine—Anxiety—Lisinopril—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Carboprost Tromethamine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Leflunomide—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Carboprost Tromethamine—Lethargy—Methotrexate—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Carboprost Tromethamine—Vomiting—Mometasone—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Prednisone—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Carboprost Tromethamine—Rash—Mometasone—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Carboprost Tromethamine—Asthenia—Captopril—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Mometasone—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Carboprost Tromethamine—Headache—Mometasone—systemic scleroderma	0.002	0.002	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Carboprost Tromethamine—Pain—Leflunomide—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Carboprost Tromethamine—Infection—Lisinopril—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Carboprost Tromethamine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Carboprost Tromethamine—Shock—Lisinopril—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Carboprost Tromethamine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Lisinopril—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Azathioprine—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Captopril—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Carboprost Tromethamine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Carboprost Tromethamine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Carboprost Tromethamine—Nausea—Mometasone—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Carboprost Tromethamine—Pain—Mycophenolic acid—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Carboprost Tromethamine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Carboprost Tromethamine—Cough—Mycophenolate mofetil—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Carboprost Tromethamine—Dizziness—Captopril—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Carboprost Tromethamine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Leflunomide—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Carboprost Tromethamine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Carboprost Tromethamine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Carboprost Tromethamine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Lisinopril—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Carboprost Tromethamine—Vomiting—Captopril—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Lisinopril—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Carboprost Tromethamine—Rash—Captopril—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Captopril—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Carboprost Tromethamine—Somnolence—Lisinopril—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Carboprost Tromethamine—Headache—Captopril—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Carboprost Tromethamine—Asthma—Methotrexate—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Carboprost Tromethamine—Infection—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Carboprost Tromethamine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Leflunomide—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Carboprost Tromethamine—Pain—Lisinopril—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Azathioprine—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Carboprost Tromethamine—Nausea—Captopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Carboprost Tromethamine—Asthenia—Leflunomide—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Carboprost Tromethamine—Dizziness—Azathioprine—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Carboprost Tromethamine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Leflunomide—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Lisinopril—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Carboprost Tromethamine—Vomiting—Azathioprine—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Carboprost Tromethamine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Methotrexate—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Carboprost Tromethamine—Rash—Azathioprine—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Azathioprine—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Carboprost Tromethamine—Flushing—Prednisone—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Carboprost Tromethamine—Headache—Azathioprine—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Carboprost Tromethamine—Dizziness—Leflunomide—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Carboprost Tromethamine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Carboprost Tromethamine—Vomiting—Leflunomide—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Carboprost Tromethamine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Methotrexate—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Carboprost Tromethamine—Rash—Leflunomide—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Leflunomide—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Carboprost Tromethamine—Nausea—Azathioprine—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Carboprost Tromethamine—Headache—Leflunomide—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Carboprost Tromethamine—Asthenia—Lisinopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Carboprost Tromethamine—Vomiting—Mycophenolic acid—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Carboprost Tromethamine—Rash—Mycophenolic acid—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Carboprost Tromethamine—Headache—Mycophenolic acid—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Carboprost Tromethamine—Nausea—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Lisinopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Carboprost Tromethamine—Angioedema—Prednisone—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Carboprost Tromethamine—Dizziness—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Carboprost Tromethamine—Nausea—Mycophenolic acid—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Carboprost Tromethamine—Vertigo—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Carboprost Tromethamine—Syncope—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Methotrexate—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Carboprost Tromethamine—Vomiting—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Carboprost Tromethamine—Rash—Lisinopril—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Lisinopril—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Carboprost Tromethamine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Carboprost Tromethamine—Hypertension—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Carboprost Tromethamine—Chills—Methotrexate—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Carboprost Tromethamine—Headache—Lisinopril—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Carboprost Tromethamine—Myalgia—Prednisone—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Carboprost Tromethamine—Anxiety—Prednisone—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Carboprost Tromethamine—Nausea—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Carboprost Tromethamine—Infection—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Carboprost Tromethamine—Back pain—Methotrexate—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Carboprost Tromethamine—Shock—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Carboprost Tromethamine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Carboprost Tromethamine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Carboprost Tromethamine—Rash—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Carboprost Tromethamine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Carboprost Tromethamine—Vertigo—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Carboprost Tromethamine—Cough—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Carboprost Tromethamine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Carboprost Tromethamine—Chest pain—Methotrexate—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Carboprost Tromethamine—Myalgia—Methotrexate—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000987	0.000987	CcSEcCtD
Carboprost Tromethamine—Infection—Methotrexate—systemic scleroderma	0.000981	0.000981	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000954	0.000954	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Prednisone—systemic scleroderma	0.000934	0.000934	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000899	0.000899	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Methotrexate—systemic scleroderma	0.000886	0.000886	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Methotrexate—systemic scleroderma	0.00088	0.00088	CcSEcCtD
Carboprost Tromethamine—Somnolence—Methotrexate—systemic scleroderma	0.000877	0.000877	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Prednisone—systemic scleroderma	0.00087	0.00087	CcSEcCtD
Carboprost Tromethamine—Asthenia—Prednisone—systemic scleroderma	0.000847	0.000847	CcSEcCtD
Carboprost Tromethamine—Pain—Methotrexate—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Prednisone—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Carboprost Tromethamine—Dizziness—Prednisone—systemic scleroderma	0.000781	0.000781	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Methotrexate—systemic scleroderma	0.00078	0.00078	CcSEcCtD
Carboprost Tromethamine—Vomiting—Prednisone—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Carboprost Tromethamine—Rash—Prednisone—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Prednisone—systemic scleroderma	0.000744	0.000744	CcSEcCtD
Carboprost Tromethamine—Headache—Prednisone—systemic scleroderma	0.00074	0.00074	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000727	0.000727	CcSEcCtD
Carboprost Tromethamine—Asthenia—Methotrexate—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Carboprost Tromethamine—Nausea—Prednisone—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Methotrexate—systemic scleroderma	0.000675	0.000675	CcSEcCtD
Carboprost Tromethamine—Dizziness—Methotrexate—systemic scleroderma	0.000653	0.000653	CcSEcCtD
Carboprost Tromethamine—Vomiting—Methotrexate—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Carboprost Tromethamine—Rash—Methotrexate—systemic scleroderma	0.000622	0.000622	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Methotrexate—systemic scleroderma	0.000622	0.000622	CcSEcCtD
Carboprost Tromethamine—Headache—Methotrexate—systemic scleroderma	0.000618	0.000618	CcSEcCtD
Carboprost Tromethamine—Nausea—Methotrexate—systemic scleroderma	0.000586	0.000586	CcSEcCtD
